On the other hand, we have populations of patients, who were diagnosed with breast cancers carrying specific molecules HER-2—a potential vaccination target and who would greatly benefit from therapeutic vaccines, but no vaccines are available. The gene discussed is ERBB2; the disease is breast carcinoma.